Cargando…

Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma

PURPOSE: Based on improvements of progression-free survival (PFS), new agents for metastatic renal cell carcinoma (mRCC) have been approved. It is assumed that one of the benefits is a delay in health-related quality of life (HRQoL) deterioration as a result of a delay in progression of disease. How...

Descripción completa

Detalles Bibliográficos
Autores principales: de Groot, S., Redekop, W. K., Versteegh, M. M., Sleijfer, S., Oosterwijk, E., Kiemeney, L. A. L. M., Uyl-de Groot, C. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770482/
https://www.ncbi.nlm.nih.gov/pubmed/28917029
http://dx.doi.org/10.1007/s11136-017-1704-4